Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Wen Shi Lee & Olga Amengual. (2020) B cells targeting therapy in the management of systemic lupus erythematosus. Immunological Medicine 43:1, pages 16-35.
Read now
Read now
A. Bilgic & D. F. Murrell. (2019) What is novel in the clinical management of pemphigus. Expert Review of Clinical Pharmacology 12:10, pages 973-980.
Read now
Read now
Kruti Sheth Nair & Chaitra Ujjani. (2015) The expanding role of bendamustine in chronic lymphocytic leukemia. Blood and Lymphatic Cancer: Targets and Therapy 5, pages 65-74.
Read now
Read now
Articles from other publishers (10)
Argelia Calvillo-Robledo, Cynthia Ramírez-Farías, Fernando Valdez-Urias, Erika P. Huerta-Carreón & Andrés Quintanar-Stephano. (2023) Arginine vasopressin hormone receptor antagonists in experimental autoimmune encephalomyelitis rodent models: A new approach for human multiple sclerosis treatment. Frontiers in Neuroscience 17.
Crossref
Crossref
Xue Gong, Dong Zhou & Zhen Hong. (2023) A novel use and dramatic efficacy of ofatumumab for the treatment of anti-N-methyl-D-aspartate receptor encephalitis: a report of two cases. Therapeutic Advances in Neurological Disorders 16, pages 175628642311618.
Crossref
Crossref
Stephen L Hauser, Anne H Cross, Kevin Winthrop, Heinz Wiendl, Jacqueline Nicholas, Sven G Meuth, Paul S Giacomini, Francesco Saccà, Linda Mancione, Ronald Zielman, Morten Bagger, Ayan Das Gupta, Dieter A Häring, Valentine Jehl, Bernd C Kieseier, Ratnakar Pingili, Dee Stoneman, Wendy Su, Roman Willi & Ludwig Kappos. (2022) Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years. Multiple Sclerosis Journal 28:10, pages 1576-1590.
Crossref
Crossref
Ramya Talanki Manjunatha, Salma Habib, Sai Lahari Sangaraju, Daniela Yepez & Xavier A Grandes. (2022) Multiple Sclerosis: Therapeutic Strategies on the Horizon. Cureus.
Crossref
Crossref
Maxime Teisseyre, Marion Cremoni, Sonia Boyer-Suavet, Caroline Ruetsch, Daisy Graça, Vincent L. M. Esnault, Vesna Brglez & Barbara Seitz-Polski. (2022) Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy. Frontiers in Immunology 13.
Crossref
Crossref
Amit Bar-Or, Heinz Wiendl, Xavier Montalban, Enrique Alvarez, Maria Davydovskaya, Silvia R Delgado, Evgeniy P Evdoshenko, Natasa Giedraitiene, Katrin Gross-Paju, Sulev Haldre, Craig E Herrman, Guillermo Izquierdo, Guntis Karelis, Fritz Leutmezer, Miroslav Mares, Jose E Meca-Lallana, Dalia Mickeviciene, Jacqueline Nicholas, Derrick S Robertson, Denis V Sazonov, Kenneth Sharlin, Bharathy Sundaram, Natalia Totolyan, Marta Vachova, Martin Valis, Morten Bagger, Dieter A Häring, Inga Ludwig, Roman Willi, Martin Zalesak, Wendy Su, Martin Merschhemke & Edward J Fox. (2021) Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study. Multiple Sclerosis Journal 28:6, pages 910-924.
Crossref
Crossref
Ashley Y. Choi, Miriam Manook, Danae Olaso, Brian Ezekian, Jaeberm Park, Kyle Freischlag, Annette Jackson, Stuart Knechtle & Jean Kwun. (2021) Emerging New Approaches in Desensitization: Targeted Therapies for HLA Sensitization. Frontiers in Immunology 12.
Crossref
Crossref
Siyu Liu, Marcell Costa de Medeiros, Evan M. Fernandez, Katie R. Zarins, Raymond G. Cavalcante, Tingting Qin, Gregory T. Wolf, Maria E. Figueroa, Nisha J. D’Silva, Laura S. Rozek & Maureen A. Sartor. (2020) 5-Hydroxymethylation highlights the heterogeneity in keratinization and cell junctions in head and neck cancers. Clinical Epigenetics 12:1.
Crossref
Crossref
F Speth, C Hinze & R Häfner. (2018) Combination of ofatumumab and fresh frozen plasma in hypocomplementemic systemic lupus erythematosus: a case report. Lupus 27:8, pages 1395-1396.
Crossref
Crossref
Shalom A. Gurjar, Jeremy P. Derrick, Rebecca J. Dearman, Robin Thorpe, Simon Hufton, Ian Kimber & Meenu Wadhwa. (2017) Surrogate CD16-expressing effector cell lines for determining the bioactivity of therapeutic monoclonal antibodies. Journal of Pharmaceutical and Biomedical Analysis 143, pages 188-198.
Crossref
Crossref